Objective: To assess the efficacy and safety of leflunomide in active ankylosing spondylitis (AS) compared with placebo in a 24 week pilot study. Methods: In a single centre randomised, double blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback